Dateline NBC Re-Examines Their "Follicle 5" After One Year of Treatments with Five Different Products for Thin Hair

After one year of usage, the HairMax LaserComb shows positive results and draws praise from it's volunteer in the Dateline NBC independent study.

Boca Raton, FL, August 1, 2005-Dateline NBC aired Sunday, July 31, 2005, the conclusion of its 12-month independent examination of five popular treatments available to men with thin hair. The story tracked the successes and failures of each man's experience with an assigned treatment. The treatments used included: hair transplant surgery, Propecia, the combination of Propecia and Monoxidil, Viviscal and the HairMax LaserComb.

Dr. Paolo Romanelli, a professor with the University of Miami's Dermatology Department, examined the volunteers at the start of the project, at six months and again after 1 year. In his opinion the HairMax LaserComb continued to show positive results after 12-months of use, further validating that the LaserComb continues to show incremental benefits in long-term users.

Volunteer "George" was the only participant using a non-surgical treatment who stated enthusiastically that he would absolutely continue with his HairMax LaserComb treatment due to the benefits both he and Dr. Romanelli noted.


Download a complete transcription from the July 31, 2005 broadcast

About Lexington International, LLC
Based in Boca Raton, Florida Lexington International manufactures and distributes the HairMax LaserComb to more than 69 countries and has provided new hope and satisfaction to tens of thousand of customers since 2001.  The HairMax LaserComb is based on 18 years of international research and studies on the effects of Low Level Laser use.  Both the press and users alike have universally taken to the HairMax LaserComb.  In addition to the Dateline series, coverage has included TIME Magazine, as one of their inventions of the year, as well as the November 2004 issue of Good Housekeeping Magazine.

Lexington International is currently conducting clinical studies to be presented to the FDA and anticipates the HairMax LaserComb becoming recognized as a medical device by the end of 2005.